Market Overview
ASX 200 Index
The Weekly Finger: Don Tzu’s Masterclass, The Acid Trip, and the Adelaide Renaissance
Geopolitics back in focus as Hormuz block tightens energy markets; Adelaide Resources Rising Stars hints at a renewed Aussie resources rally.
The Race to Find Monthly Income
Solaris launches ASX LIC SET to deliver monthly franked income, targeting $300m; first dividend August 2026 as hybrids wind down.
Weekly Wrap: Strong Week Despite Late Fade
ASX up 4.4% for the week; strongest since Oct 2022, despite Friday fade. Magellan-Barrenjoey merger approved; Telix jumps on US regulator nod; Iran talks ahead.
Financial Adviser Shortage Starting to Get Serious
Australia faces a deepening financial-adviser shortage as retirees outpace entrants; 15.9 million Australians have unmet advice needs, FAAA warns.
Boss Energy Reports Updated Uranium Resource Estimates for Gould’s Dam and Jason’s Deposit
Boss Energy updates Gould’s Dam and Jason’s Deposit uranium resources to 33.1Mlb and 12.0Mlb U; accelerated Honeymoon-style development with H2 approvals.
Weekly Wrap: A record close and 3.7% month a big thumbs up
ASX 200 finishes at record close, up 3.7% in Feb as BHP profits beat and banks top forecasts; Block rockets on staff cuts; rare-earths rally lifts Lynas/Iluka.
Boss Energy Reports $36.2m Positive Net Cash Flow from Honeymoon Uranium Project
Boss Energy (ASX: BOE) logs $36.2m positive net cash flow from Honeymoon uranium project; six months to Dec lift in uranium sales, lower C1 costs boost outlook.
Weekly Wrap: ASX slips on war fears as earnings beat expectations buoy week
War fears nudge ASX 200 lower despite QBE's 21% profit surge; energy gains lift oil names, tech slumps; Guzman sinks below float.
Neila Creek Site Visit Takeaways and What’s Ahead for Golden Globe's Gold Projects
Golden Globe Resources advances Neila Creek: two holes complete, third underway; assay results pending as gold and copper prices rally.
Axel REE Selects Woolrich as First Field Trial Site for Rare Earth ISR at Caladão
Axel REE selects Woolrich for its first ISR field trial at Caladão, moving from lab work to field-scale development in Brazil (ASX: AXL).
EV Resources Advances Mexico Antimony Hub Toward Near-Term Production
EV Resources pushes Los Lirios toward near-term production with geophysics, 11 drill holes, and Tecomatlán plant refurbishment.
International Graphite Advances Alkeemia Graphite Purification Push with 99.9%-Plus TGC Results
IG6 reports 99.9%+ TGC purification in seven samples, backing a 51:49 JV with ALKEEMIA to build Porto Marghera graphite purification hub, starting 2026.
Pacific Edge Test Volumes Rise 2.7% in Q4 on Payer Expansion
Pacific Edge (PEB) Q4 test volumes rise 2.7% on payer expansion; eyes Medicare LCD draft by Sept 2026 as coverage broadens, signaling regulatory momentum.
Imricor Medical Systems Advances US Strategy with Pediatric Label Expansion Submission
Imricor submits pediatric NorthStar label via 510(k) to FDA, targeting 250 US children's hospitals; clearance expected this quarter to drive US growth.
Amplia Therapeutics Halts AMPLICITY Trial Recruitment After Chemo-Related DLTs
Amplia Therapeutics halts AMPLICITY recruitment after DLTs with narmafotinib mFOLFIRINOX; pivots to new combos, delaying readouts and raising investor risk.
Firebrick Pharma Raises $1.5m to Advance Product Development and Commercial Expansion
Firebrick raises $1.5m via 31.9m shares at $0.047, 16.5% discount to VWAP with 1-for-2 options; Indonesia grants Nasodine approval, unlocking SE Asia growth.
Xref Reports Strong Q3 FY26 as ARR Surges 54% and EBITDA Turns Positive
Xref Q3 FY26: ARR up 54% to $10.6m; EBITDA positive at $0.3m as new platform hits 97% of sales — profitability turnaround.
EML Payments Slashes FY26 EBITDA Guidance by 20% on Implementation Delays and Weak Trading
EML Payments cuts FY26 EBITDA guidance ~20% to $47m-$50m on delayed go-lives and weaker Northern Hemisphere trading.
Amaero Plans to Double Production after Receiving $7.8m Titanium Powder Order
Amaero (ASX: 3DA) wins A$7.8m titanium powder order, plans 100% production lift in FY2027 as it doubles capacity; US re-domiciliation underway.
IODM Partners with TransferMate for 283 US University Rollout, Boosts Convera Revenue Share
IODM expands into US higher ed with 283 universities via TransferMate; Convera UK deal ups revenue share to 30% as AUD 1m funding backs expansion.
ADX Energy Eyes Near-Term Drilling Catalyst with HOCH-1 Shallow Gas Well Mobilisation Underway
ADX Energy mobilises HOCH-1 shallow gas well in Austria; spud Apr 16, 2026; first of three 2026 wells; ~8.0 BCF mean resources; near-term catalyst.
Central Petroleum Signs Major Gas Deal for Palm Valley Expansion
Central Petroleum signs multi-year gas deal with NT Government powering Palm Valley expansion; 21 PJ to 2034, ~40% output boost; first gas by H2 2026.
Invictus Energy Finalises Key EIA Renewal Paving Way for Musuma-1 and Mukuyu Programs
Invictus Energy secures EIA renewal for Cabora Bassa to Mar 2027; PPSA expected in April, unlocking Musuma-1 and Mukuyu drills and Zimbabwe appraisal.
Finder Energy Inks Non-Binding Rig-Sharing LOI with SundaGas Offshore Timor-Leste
Finder Energy signs rig-sharing LOI with SundaGas for Timor-Leste drilling, boosting KTJ milestones ahead of mid-2026 FID and 2027 first oil.
Atomos Secures $10m CBA Finance Facility and Cuts Existing Loan Costs
Atomos secures $10m CBA facility, cuts existing loan pricing by 7% to 13%, reaffirms FY26 targets: revenue >$47.5m, EBITDA >$3.8m.
Australian Unity Office Fund Eyes Delisting and Wind-up after Selling Last Remaining Asset
Australian Unity Office Fund eyes delisting and wind-up after conditional $40m sale of its last asset; targets $0.37-$0.38 per unit, May 2026 EGM; FIRB risk.
Multistack International Agrees to Sell Assets and Liabilities in Strategic Pivot
Multistack to sell nearly all assets to Willing Y Limited, exiting loss-making core; aims for June 2026 completion with cash buffer, amid going-concern risk.
KMD Brands Completes $44.2M Institutional Capital Raise
KMD Brands closes NZ$44.2m institutional raise at NZ$0.06, 79% take-up; trading resumes 2 Apr; retail offer opens 7 Apr, aiming NZ$21.1m.
Never Miss a Market Move
Get the latest ASX small-cap news, exclusive CEO interviews, and market insights delivered to your inbox.
Free weekly newsletter. Unsubscribe anytime.
Ceretas secures $1m for breakthrough ultrasound therapy for dementia, eyes potential IPO
Australian MedTech company Ceretas has successfully secured $1 million in seed funding to advance its low-cost, portable and non-invasive ultrasound device aimed at treating dementia and other neurological conditions. This funding positions the company closer to a potential IPO as it progresses through clinical research and regulatory steps. Initial capital raise fuels development The recent […]
Stormeur IPO to expand non-surgical cosmetics empire
Non-surgical cosmetics group Stormeur has launched a $7 million capital raising to fund the opening of four new Cosmetique clinics along Australia’s east coast. The company announced an initial public offering (IPO) last month based on a growth strategy that includes two new clinics in Sydney and two in Melbourne, to be established within 24 […]
ASX anticipates surge of IPOs later in 2024
Australia’s pipeline of initial public offerings (IPOs) is expected to ramp up in the new year thanks to a cyclical market on the rebound. Anticipated listings for the second half of 2024 include companies in the industrials, mining and consumer discretionary sectors such as cars, household appliances, specialty items, luxury goods and leisure. According to […]
Guzman y Gomez sets sights on ASX listing with IPO to fund aggressive expansion
In a bold move set to shake up Australia’s fast food landscape, Mexican-inspired chain Guzman y Gomez (GYG) is preparing to make its debut on the Australian Securities Exchange (ASX). The company’s upcoming initial public offering (IPO) is not just another corporate event—it’s a statement of GYG’s ambition to redefine fast food in this country. […]